Antibody Engineering and Therapeutics EU 2025
AbCellera will be presenting a poster: PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer at Antibody Engineering & Therapeutics Europe 2025.
Event details.
Jessica Fernandes Scortecci
Research Scientist II
Presentation
PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer
Date and Time
June 10-12, 2025
Location
Basel, Switzerland